GU Cancers 2018 | MRI and MRI-directed biopsies for the diagnosis of prostate cancer
Mark Emberton
The utilization of MRI for the diagnosis of prostate cancer in men at risk is relatively new. In this interview, filmed at the 2018 Genitourinary Cancers Symposium, in San Francisco, CA, Mark Emberton, MD, FRCS, of University College London, London, UK, explains why the use of MRI is important for the diagnosis and treatment of prostate cancer. Prof. Emberton also explains the problems that can arise from not determining tumor location and volume at diagnosis.
Related videos
2:19
NKTR-214 + nivolumab in first-line advanced/mUC: updated results from PIVOT-02
Arlene Siefker-Radtke
0:54
"All bladder, all the time" - Highlights from the 2019 Genitourinary Cancers Symposium
Arlene Siefker-Radtke
3:25
Determining the optimal local treatment for muscle-invasive bladder cancer
Jeanny Aragon-Ching
2:06
PRIMETEST: evaluating retroperitoneal lymph node dissection
Jeanny Aragon-Ching
1:34
Access limitations: the key challenges facing RCC treatment in France
Laurence Albiges
